Ledger.Open graph →
SEC Form D · filed July 14, 2020

Immutrix Therapeutics, Inc

Offering
$15.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RAPID CITY, SD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Michael Novogratz · New York, NYDirectorKarla Bodden · George Town, Grand Cayman, Cayman IslandsDirectorBrent A. Phillips · Rapid City, SDDirectorStephanie L. D?Urso · Rapid City, SDDirectorRoy A. Ketel · Rapid City, SDExec · DirectorJoan B. Berkowitz · New York, NYExec · DirectorChris Joyce · London, United KingdomDirectorCraig R. Hansen · Rapid City, SDDirectorJonathan Crowther · Grand Cayman, Cayman IslandsExec · DirectorVincent R. O'Donnell · Auburndale, MADirectorRoy A. Ketel · Rapid City, SDExec · DirectorStephanie L. D?Urso · Rapid City, SDDirectorCarol A. Rae · Rapid City, SDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗